CID 9949848

Medrogestone

Structural Information

Molecular Formula
C23H32O2
SMILES
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@]3(C)C(=O)C)C)[C@@]4(C1=CC(=O)CC4)C
InChI
InChI=1S/C23H32O2/c1-14-12-17-18(21(3)9-6-16(25)13-20(14)21)7-11-23(5)19(17)8-10-22(23,4)15(2)24/h12-13,17-19H,6-11H2,1-5H3/t17-,18+,19+,21-,22-,23+/m1/s1
InChIKey
HCFSGRMEEXUOSS-JXEXPEPMSA-N
Compound name
(8R,9S,10R,13S,14S,17S)-17-acetyl-6,10,13,17-tetramethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

113
References

4185
Patents

340.24023 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 341.24751 185.4
[M+Na]+ 363.22945 195.4
[M+NH4]+ 358.27405 199.0
[M+K]+ 379.20339 183.8
[M-H]- 339.23295 188.1
[M+Na-2H]- 361.21490 189.4
[M]+ 340.23968 188.1
[M]- 340.24078 188.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe